Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Efficacy of Eribulin for Metastatic Breast Cancer Based on Localization of Specific Secondary Metastases: A Post Hoc AnalysisSci Rep 2020 Jul 08;[EPub Ahead of Print], J O'Shaughnessy, J Cortes, C Twelves, LJ Goldstein, K Alexis, R Xie, C Barrios, T Ueno
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.